Examining Written Disclosure as a Treatment for Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder
About this trial
This is an interventional treatment trial for Post-Traumatic Stress Disorder focused on measuring PTSD, Written Disclosure, Written Emotional Disclosure, Narrative Exposure, Narrative Writing, Motor Vehicle Accident
Eligibility Criteria
Inclusion Criteria:
- Primary diagnosis of post-traumatic stress disorder
- Involved in motor vehicle accident that occurred at least 3 months ago
Exclusion Criteria:
- Current diagnosis of mania, hypomania, bipolar depression, psychotic disorder, substance abuse disorder, or severe depression
- History of psychosis
- Active suicidality or history of two or more suicide gestures or attempts in the past year
- Significant cognitive impairment
- Current participation in a psychosocial treatment, such as individual or group therapy led by a clinician
Sites / Locations
- VA Boston Healthcare System, National Center for PTSD
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Group 1 Treatment in Clinic
Group 2 Treatment via telephone
Group 3 Waitlist
Participants will complete the written disclosure treatment in a clinic setting.
Participants will complete the written disclosure treatment in their homes via telephone.
Individuals will be placed on a waitlist for a period of 4 months, during which they will receive a phone call every other week to assess their suicidal ideation and post-traumatic stress disorder symptom severity.